Abstract
In addition to their use in the treatment of seizure disorders and various otherwise treatment-refractory psychiatric cases (e.g. mania), anticonvulsants have pined recognition for their beneficial effect in the treatment of aggressive behavior. In particular, carbamazepine has been consistently shown to be effective in lowering aggression regardless of psychiatric or neurological condition. Empirical studies of the effectiveness of anticonvulsants in decreasing aggression are reviewed and evaluated. Cost benefit factors related to the use of anticonvulsants in the treatment of violent individuals are evaluated. Finally, a protocol for the implementation and monitoring of anticonvulsant treatment is presented.
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call